This patent covers a method for producing a pigment epithelial cell of the eye through in vivo transfection of therapeutic genes such as neurotrophic factors, antiangiogenic factors, antioxidative factors, lysosomal factors, and/or vasodilating factors.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.